Growth Metrics

BioLineRx (BLRX) EPS (Basic) Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.31%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -79.34%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 61.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,207.14%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 -111.08%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -488.69%
Sep 30, 2025 -649.04%
Jun 30, 2025 76.64%
Mar 31, 2025 74.75%
Dec 31, 2024 102.93%
Sep 30, 2024 86.13%
Jun 30, 2024 -558.14%
Mar 31, 2024 -961.39%
Dec 31, 2023 -39.13%
Sep 30, 2023 -100.00%
Jun 30, 2023 100.00%
Mar 31, 2023 0.00%
Dec 31, 2022 22.32%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 50.00%
Dec 31, 2021 76.87%
Sep 30, 2021 50.00%
Jun 30, 2021 133.33%
Mar 31, 2021 50.00%
Dec 31, 2020 33.33%
Sep 30, 2020 33.33%
Jun 30, 2020 -175.00%
Mar 31, 2020 20.00%
Dec 31, 2019 -20.00%
Sep 30, 2019 50.00%
Jun 30, 2019 180.00%
Mar 31, 2019 16.67%
Dec 31, 2018 28.57%
Sep 30, 2018 14.29%
Jun 30, 2018 0.00%
Mar 31, 2018 25.00%
Dec 31, 2017 0.00%
Sep 30, 2017 12.50%
Jun 30, 2017 28.57%
Mar 31, 2017 -33.33%
Dec 31, 2016 10.29%
Sep 30, 2016 -3,284.88%
Jun 30, 2016 22.22%
Mar 31, 2016 40.59%
Dec 31, 2015 -66,760.29%
Jun 30, 2015 25.00%
Mar 31, 2015 -1,162.50%
Dec 31, 2014 99.42%
Jun 30, 2014 -500.00%
Mar 31, 2014 60.00%